Lewis Gryziewicz - Macrocure Vice President - Regulatory Affairs
President
Dr. Lewis Gryziewicz is Vice President Regulatory Affairs of Macrocure Ltd. Prior to joining Macrocure, Dr. Gryziewicz spent 16 years at Allergan, 10 years at Johnson Johnson and 3 years at BristolMyers Squib. At Allergan, Dr. Gryziewicz held seniorlevel positions within Regulatory Affairs, most recently as Global Regulatory Liaison for Ophthalmology, where he was responsible for the submission and approval of global marketing applications, liaising with global regulatory agencies, and regulatory strategy, which led to product approvals, including US and European Union approvals of Ozurdex and Combigan and approval in the US and Japan for Alphagan P and Lumigan, among others. During his tenure at Johnson Johnson, Dr. Gryziewicz also held positions in Regulatory Affairs and was responsible for the approval of the acne indication for Ortho TriCyclen and the removal of the black box warning for Renova since 2015.
Tenure | 9 years |
Professional Marks | MBA |
Phone | 972 3 923 5556 |
Web | http://www.macrocure.com |
Macrocure Management Efficiency
The company has return on total asset (ROA) of (0.193) % which means that it has lost $0.193 on every $100 spent on assets. This is way below average. Macrocure's management efficiency ratios could be used to measure how well Macrocure manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Steve Hightower | Presidio Property Trust | 56 | |
Suzanne Boda | American Airlines Group | N/A | |
William Ris | American Airlines Group | N/A | |
Stephen Mackey | MGIC Investment Corp | 57 | |
Paula Maggio | MGIC Investment Corp | 55 | |
Andrew Nocella | American Airlines Group | 45 | |
Kurt Stache | American Airlines Group | N/A | |
Gregory Chi | MGIC Investment Corp | 57 | |
Hector Adler | American Airlines Group | N/A | |
James Hughes | MGIC Investment Corp | 61 | |
Domas Girtavicius | American Airlines Group | 28 | |
Danielle Kirgan | American Airlines Group | N/A | |
Salvatore Miosi | MGIC Investment Corp | 56 | |
Thomas Lauer | Fidus Investment Corp | 56 | |
Robert Candelmo | MGIC Investment Corp | 60 | |
Alison Taylor | American Airlines Group | N/A | |
Nathaniel Colson | MGIC Investment Corp | 40 | |
Tomas Sidlauskas | American Airlines Group | 29 | |
Elise Eberwein | American Airlines Group | 52 | |
Scott Kirby | American Airlines Group | 46 |
Management Performance
Return On Asset | -0.19 |
Macrocure Leadership Team
Elected by the shareholders, the Macrocure's board of directors comprises two types of representatives: Macrocure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Macrocure. The board's role is to monitor Macrocure's management team and ensure that shareholders' interests are well served. Macrocure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Macrocure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lewis Gryziewicz, Vice President - Regulatory Affairs | ||
Danna Moran, Marketing and Sales Manager | ||
Alan Smith, Head - North American Operations | ||
Nissim Mashiach, Pres and CEO | ||
Ramesh Tharuvai, VP of Operations | ||
David Ami, Chairman of the Board and Co-Founder | ||
Mark Page, CFO |
Macrocure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Macrocure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.19 | |||
Current Valuation | 9.79 M | |||
Shares Outstanding | 16.26 M | |||
Number Of Shares Shorted | 76.85 K | |||
Price To Earning | (1.09) X | |||
Price To Book | 1.06 X | |||
Net Income | (21.1 M) | |||
Cash And Equivalents | 20.97 M | |||
Cash Per Share | 1.44 X | |||
Debt To Equity | 0.05 % |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Macrocure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Macrocure's short interest history, or implied volatility extrapolated from Macrocure options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Macrocure Stock
If you are still planning to invest in Macrocure check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Macrocure's history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |